OpenVSafe by OpenVAERS
Search V-safe

YHU-71778-00678

3 vaccinations 7 coded responses 39 check-ins 7 free-text entries 3 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
967 / HI
Registered
2021-02-10
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-10
    Registered in v-safe
  2. 2021-02-10
    Dose 1 — Pfizer-BioNTech
  3. 2021-02-10
    Survey response — day 0, dose 1
    MedDRA: Dizziness — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Lightheaded/woozy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-02-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness
    Adult check-in
  5. 2021-02-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · Headache
    Adult check-in
  6. 2021-02-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  7. 2021-02-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Muscle or body aches · Be unable to do your normal daily activities
    Adult check-in
  8. 2021-02-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain
    Adult check-in
  10. 2021-02-17
    Health check-in — day 7, dose 1
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  11. 2021-02-24
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-03
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-03-10
    Dose 2 — Pfizer-BioNTech
  14. 2021-03-10
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness
    Adult check-in
  15. 2021-03-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain
    Adult check-in
  16. 2021-03-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain
    Free text: Tender swollen area just above left clavicle
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-03-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Swelling, Tenderness — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain
    Free text: Swollen, tender area just above left clavicle
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-03-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fever · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  19. 2021-03-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Diarrhea
    Adult check-in
  20. 2021-03-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Be unable to work
    Adult check-in
  21. 2021-03-17
    Health check-in — day 7, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness, Diarrhea
    Adult check-in
  22. 2021-03-24
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  23. 2021-03-31
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-04-07
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  25. 2021-04-14
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  26. 2021-04-21
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  27. 2021-06-09
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-09-08
    Survey response — 6 months, dose 2
    MedDRA: Decreased appetite, Diarrhoea, Dizziness, Headache, Nausea, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Fever, headaches, dizziness, nausea, loss of appetite, diarrhea. Lasted almost a month.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-09-08
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  30. 2021-09-14
  31. 2021-11-10
    Dose 3 — Pfizer-BioNTech
  32. 2021-11-12
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fever · Chills, Headache, Fatigue or tiredness
    Adult check-in
  33. 2021-11-13
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-11-14
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-11-15
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-11-16
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  37. 2021-11-19
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  38. 2021-11-24
    Survey response — day 14, dose 3
    MedDRA: Laboratory test abnormal — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Abnormal lab results regarding Kidney function
    MedDRA releases: 2024-11 · check-in free text available
  39. 2021-11-24
    Report sent to call center — day 14, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  40. 2021-12-01
    Health check-in — day 21, dose 3
    Feeling: Fair
    Adult check-in
  41. 2021-12-08
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  42. 2021-12-17
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  43. 2021-12-22
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  44. 2022-01-13
  45. 2022-02-10
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  46. 2022-05-14
    Survey response — 6 months, dose 3
    MedDRA: Abdominal distension, Acute kidney injury, Aphasia, Arthralgia, Fatigue, Myalgia, Pyrexia, Swelling — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Ongoing fatigue, muscle and joint aches, swelling/bloating, acute kidney injury, low grade fevers, difficulty remembering specific words
    MedDRA releases: 2024-11 · check-in free text available
  47. 2022-05-14
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  48. 2022-05-16
  49. 2022-11-12
    Survey response — 12 months, dose 3
    MedDRA: Dizziness, Nausea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Dizziness not linked to vertigo, blood sugar or blood pressure; often accompanied by nausea
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-02-10Pfizer-BioNTech
22021-03-10Pfizer-BioNTech
32021-11-10Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-09-08 Unsuccessful
2021-11-24 Unsuccessful
2022-05-14 Unsuccessful

Free text

Release 4 — day 0, dose 1

2021-02-10

Systemic reaction (other): Lightheaded/woozy

Release 5 — days 1–6 daily, dose 2

2021-03-12

Systemic reaction (other): Tender swollen area just above left clavicle

2021-03-13

Systemic reaction (other): Swollen, tender area just above left clavicle

Release 9 — 6 months, dose 2

2021-09-08

Symptoms: Fever, headaches, dizziness, nausea, loss of appetite, diarrhea. Lasted almost a month.

Release 10 — day 14, dose 3

2021-11-24

Symptoms: Abnormal lab results regarding Kidney function

Release 11 — 6 months, dose 3

2022-05-14

Symptoms: Ongoing fatigue, muscle and joint aches, swelling/bloating, acute kidney injury, low grade fevers, difficulty remembering specific words

Release 12 — 12 months, dose 3

2022-11-12

Symptoms: Dizziness not linked to vertigo, blood sugar or blood pressure; often accompanied by nausea

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal distension · · ✓
SDAcute kidney injury · · ✓
SDAphasia · · ✓
SDArthralgia · · ✓
SDDecreased appetite · · ✓
SDDiarrhoea · · ✓
SDDizziness · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDLaboratory test abnormal · · ✓
SDMyalgia · · ✓
SDNausea · · ✓
SDPyrexia · · ✓
SDSwelling · · ✓
SRODizziness ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROSwelling ✓ ✓ ✓
SROTenderness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release